Source Insights
Rate Regulation Can Help Redirect Providers to Compete on Non-Price Dimensions of Care
Robert Murray, Senior Health Policy Researcher July 8, 2022
This Blog provides supplementary comments on the recent Health Affairs article entitled “How Price Regulation Is Needed To Advance Market Competition” authored by Robert Berenson and Robert Murray.[1] The idea for the article was stimulated by conversations Bob Berenson and I have had in recent years regarding government administered pricing systems and market competition. Conventional U.S. health policy has asserted that these two approaches represent mutually exclusive strategies to address the issue of high and rapidly rising commercial health care prices. In our Health Affairs article, we attempt to refute …
Continue Reading Download PDF
Biden’s Executive Order Reinvigorates Competition Policy
Katie Gudiksen, Senior Health Policy Researcher and Alex Montague, Amy Y. Gu, Jaime King August 5, 2021
This blog post is copublished with Milbank Memorial Fund. On July 9, 2021, President Biden issued an Executive Order on Promoting Competition in the American Economy, announcing his intent to reinvigorate antitrust enforcement throughout US industries with a special focus on certain markets including health care. The executive order and accompanying fact sheet cites research showing that hospitals in consolidated markets charge far higher prices than hospitals with several competitors and that hospital consolidation has left many areas, especially rural communities, without good options for convenient and affordable health care …
Continue Reading Download PDF
Pharmacy Benefit Managers Under Legal Scrutiny – U.S. Supreme Court to Decide if States Can Regulate PBM Reimbursement to Pharmacies
Katie Gudiksen, Senior Health Policy Researcher and Sammy Chang October 5, 2020
On October 6, the Supreme Court will hear oral arguments in the case Rutledge v. Pharmaceutical Care Management Association (PCMA). A decision in this case will resolve whether an Arkansas law to regulate pharmacy benefit managers (PBMs), Act 900, is preempted by federal law and may affect the enforceability of similar laws passed by at least thirty-five other states.[1] Arkansas passed Act 900 to protect pharmacies from dispensing drugs at a loss. Specifically, the law requires PBMs, when challenged by a pharmacy, to raise the reimbursement rate for a drug …
Continue Reading Download PDF
Surprise Billing: Proposed Federal Solutions From Both Sides of the Aisle
Source Fellow August 11, 2020
By: Danika Rothwell, Student Fellow Paul DeWolfe needed back surgery. He knew the operation would be covered by his insurance and was careful to make sure the hospital he chose was in his insurer’s network. DeWolfe sat down and did the math. He figured his portion of the bill would cost roughly $3,000. When DeWolfe recovered from his procedure, he was shocked to receive a bill for $18,590.83.[1] Despite all his attentive preparation, some of the physicians who treated him at his in-network hospital were, in fact, out-of-network. This story …
Continue Reading Download PDF
Federal Telehealth Waivers Provide Flexibility During the COVID-19 Crisis to Expand Coverage and Access to Healthcare
Source Fellow June 30, 2020
By: Megan Pham, Student Fellow COVID-19 has upended the way individuals across the country access medical care and has made doctors’ offices and hospitals high-risk grounds for transmission. This leaves the elderly and immunocompromised who seek care especially vulnerable. In response, the U.S. Department of Human and Health Services (HHS) and Centers for Medicare and Medicaid Services (CMS) have adopted a series of waivers to allow increased access to and coverage of healthcare services through telehealth. PRE-PANDEMIC TELEHEALTH Telehealth is “the use of telecommunications and information technology to …
Continue Reading Download PDF
The Crisis of COVID-19 Heightens the Need for Surprise Billing Protections
Katie Gudiksen, Senior Health Policy Researcher April 20, 2020
[Post Updated: April 20, 2020] Earlier this year, the federal government appeared poised to address the problem of surprise billing,[1] but the coronavirus pandemic shifted policy priorities before Congress had a chance to act. While some lawmakers may try to include surprise billing protections in the next COVID-19 stimulus package, the pandemic and its ripple effects make action by lawmakers to address surprise billing critical. Surprise bills, also known as balance bills, may occur when a patient unavoidably sees an out-of-network provider for an emergency situation or unexpectedly sees an …
Continue Reading Download PDF
Obamacare: Here We Go Again…..
Jaime S. King, Executive Editor February 14, 2020
For those of you who have followed the storied trajectory of the Affordable Care Act (ACA), affectionately called Obamacare, strap yourselves in because here we go again. After months of waiting for an opinion, on December 18, 2020, which incidentally was the day of Donald Trump’s impeachment, the 5th Circuit Court of Appeals issued its opinion in Texas v. U.S., the most recent challenge to the constitutionality of the ACA. The three-judge panel ruled two to one that the individual mandate was unconstitutional in the absence of a tax penalty, …
Continue Reading Download PDF
Would House and Senate Bills to Lower Drugs Costs Achieve Savings or Affect Innovation?
Katie Gudiksen, Senior Health Policy Researcher December 9, 2019
*See 12/13/19 Update: House Passes the Elijah Cummings Lower Drug Costs Now Act (H.R. 3) Increasing the affordability of prescription drugs is of primary importance to Congress and to the nation. In this post, we review two of the federal bills receiving substantial press coverage – the Lower Drug Costs Now Act, introduced in the House by Speaker Pelosi and the Prescription Drug Pricing Reduction Act, introduced in the Senate by Senator Grassley. While the current bills may have a bumpy road to approval, we analyze the proposals in …
Continue Reading Download PDF
The Lower Health Care Costs Act: A Bipartisan Federal Effort to Improve Competition in Healthcare Markets
Katie Gudiksen, Senior Health Policy Researcher June 21, 2019
The Lower Health Care Costs Act, released in May 2019 by Senators Lamar Alexander and Patty Murray, addresses many inefficiencies in healthcare markets and has the potential to both increase competition and lower costs for healthcare services. The 195-page draft federal bill, also known as the Alexander-Murray Bill (S 1895), contains more than three dozen provisions designed to address health care costs. The bill is divided into five titles: 1) Ending Surprise Medical Bills, 2) Reducing the Prices of Prescription Drugs, 3) Improving Transparency in Health Care, 4) Improving Public …
Continue Reading Download PDF
State Progress Toward a Healthcare Public Option: The State of Washington is the Trailblazer
Katie Gudiksen, Senior Health Policy Researcher May 9, 2019
*Update: On May 13, 2019, Governor Jay Inslee signed SB 5526 into law making Washington the first state public option plan. Washington now takes the first difficult steps toward implementing the law. In the current political climate, debate continues at the state and federal level over the role of government in containing health care costs and ensuring coverage for all Americans. Specifically, in a survey done in March 2019 by the Kaiser Family Foundation, a majority of Americans (56%) supported a national health plan.[1] Little consensus, however, exists on how …
Continue Reading Download PDF